The goal of this virtual, interactive CE lecture series is to update care providers on the latest advances in fetal diagnostic criteria and optimal management to enhance their skills in prenatal diagnosis, counseling and treatment. Hosted by the Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment, this series provides a forum to delineate fetal diagnoses, nuances in fetal findings, therapies available, and the impact they can have on pregnancy management and maternal/fetal outcomes.

Upcoming Sessions • 2025

Wednesday, May 21 • 22q Part II: Prenatal Diagnosis, Classic Fetal Findings and Pregnancy Management
Presenters: Juliana Sanchez Gebb, MD, Maternal-Fetal Medicine Specialist, and Renee Wright, MS, LCGC, Genetic Counselor, Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment, Children’s Hospital of Philadelphia

Wednesday, June 11 • Fetal Giant Neck Masses and the EXIT Procedure
Presenters: Edward R. Oliver, MD, PhD, Radiologist, and Shelly Soni, MD, Maternal-Fetal Medicine Specialist, Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment, Children’s Hospital of Philadelphia

All sessions take place from 7-8:30 p.m. EST.

Sign up to attend live or receive a recording after the event.

Recordings

• 22q, What’s It To You?: This session discusses 22q11.2 deletion syndrome, the second most common chromosomal difference and a leading cause of congenital heart defects and developmental differences. Access recording »
• Advances in Craniofacial Conditions: This session reviews the pathophysiology that leads to cleft lip, describes current and ongoing research related to cleft lip, reviews the management options for patients with cleft lip diagnosed in utero and explains the importance of a multidisciplinary team for care coordination and outcomes in patients diagnosed with a cleft lip/palate. Access recording »
• Sacrococcygeal Teratoma – From Prenatal Diagnosis to Postnatal Outcomes: This session presents ultrasound techniques and approaches in evaluating fetal sacrococcygeal teratoma (SCT), discusses the prenatal counseling and management options for fetal SCT, and reviews prenatal and postnatal surgical options along with outcomes for fetal SCT. Access recording »
• Detailed Fetal Imaging and Whole Exome Sequencing/Whole Genome Sequencing Can Reveal the Diagnosis in Complex Cases with Normal Microarray: This session presents an overview of prenatal exome and genome sequencing (ES and GS), review the CHOP/CFDT experience with ES/GS on anomalous fetuses, discuss benefits and limitations of utilizing these technologies prenatally, and review case examples. Access recording »
• What Fetal Magnetic Resonance Imaging (MRI) Adds to Ultrasound in Complex Brain Malformations: This session shows participants how to identify maternal and fetal indications for various fetal interventions and associated maternal-fetal outcomes, discuss prenatal counseling, obstetrical management, fetal therapy options, fetal surveillance and delivery planning for fetuses with select fetal anomalies, and discusses ongoing research endeavors related to maternal-fetal health and childhood outcomes. Access recording »
• Selective Fetal Growth Restriction: What We Know and What We Don’t: This session shows learners how to identify maternal and fetal indications for various fetal interventions and associated maternal-fetal outcomes and discuss prenatal counseling, obstetrical management, fetal therapy options, fetal surveillance and delivery planning for fetuses with select fetal anomalies. Access recording »
• Congenital Trach Congenital Tracheoesophageal Anomalies: From Prenatal Diagnosis to Postnatal Management: This session reviews prenatal ultrasound (US) and magnetic resonance imaging (MRI) findings of esophageal atresia and/or tracheo-esophageal fistula (EA/TEF). Access recording »
• The Spectrum of Fetal Congenital Heart Disease: Diagnostic Characterization and Perinatal Strategies of Care: This session reviews fetal diagnostic criteria and optimal management to enhance skills in prenatal diagnosis, counseling, and treatment for babies with fetal congenital heart disease. Access recording »
• Respecting the Unexpected: Patient Guided Collaborative Counseling in the Setting of a Life-threatening Fetal Diagnosis: Learn the collaboration of care triangle, the goals of care in life threatening fetal diagnoses and how to frame the discussion. Access recording »
• What Placental Pathology Adds to a (Fetal) Center: Learn about the four most important patterns of placental injury, the importance of submitting the placenta for pathologic examination, and the guidelines for placental pathologic examination. Access recording »
• CDH/FETO: Review the care, management and surgical options for mothers carrying babies with congenital diaphragmatic hernia (CDH), including fetoscopic endoluminal tracheal occlusion (FETO), a procedure recently featured in the New England Journal of Medicine. Access recording »
• Fetal/Neonatal Renal Failure: Review the diagnosis and management of fetuses with renal failure, including the option of the Renal Anhydramnios Fetal Therapy (RAFT) trial. Access recording »
• MMC: Review the diagnosis and management of fetuses myelomeningocele (MMC). Access recording »
• Perinatal Palliative Care: Services available to families. Access recording »
• Twin-twin Transfusion Syndrome: Review fetal diagnostic criteria and optimal management to enhance skills in prenatal diagnosis, counseling and treatment for TTTS. Access recording »
• Cleft Lip & Palate: Review fetal diagnostic criteria and optimal management to enhance skills in prenatal diagnosis, counseling and treatment for babies with cleft lip and palate. Access recording »
• Prenatal Diagnosis and Management of Hydrops: Access recording »
• Prenatal Management and Surgical Care of Lung Lesions: Recording coming soon.
• Bladder Exstrophy and the Multi-institutional Bladder Exstrophy Consortium/MIBEC (Douglas A. Canning Memorial Lecture): Access recording »
• Fetal Encephalocele: Prenatal Diagnosis to Postnatal Management and Outcomes: Access recording »
• Prenatal and Postnatal Management of Twin Anemia Polycythemia Sequence (TAPS): Access recording »

Visit www.chop.edu/fetal-courses for a full library of fetal medicine education.

Objectives

Upon completion of these activities, participants will be able to:

• Identify maternal and fetal indications for various fetal interventions and associated maternal-fetal outcomes.
• Discuss prenatal counseling, obstetrical management, fetal therapy options, fetal surveillance and delivery planning for fetuses with select fetal anomalies.
• Discuss ongoing research endeavors related to maternal-fetal health and childhood outcomes.

Participants

This educational opportunity is targeted to a diverse audience that includes: Obstetricians, Maternal-Fetal Medicine Physicians, Surgeons, Nurses, Sonographers, Radiologists, Neonatologists, Genetic Counselors, Fetal Therapy Coordinators, Advanced Practice Nurses.

Each session will be co-led by one of our maternal-fetal medicine specialists, who are listed below:

• Julianna Sanchez Gebb, MD
• Nahla Khalek, MD, MPH
• Shelly Soni, MD

CE

CE credits will be offered for each event. To be eligible for credit, you must attend the full event and complete a post-event evaluation via email (will be sent within 24 hours to the email you registered with). Feel free to sign up for one or more of the above listed sessions.

JOINT ACCREDITATION STATEMENT: In support of improving patient care, this activity has been planned and implemented by the Children’s Hospital of Philadelphia. The Children’s Hospital of Philadelphia is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA CREDIT DESIGNATION STATEMENT: Children's Hospital of Philadelphia designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE STATEMENT: Juliana Gebb, MD (Course Director) and Amy Gettlin (CE Planner) and others as appropriate have no relevant financial relationship with an ineligible company to disclose.

Contact

Kristen Behrens
(267) 426-5297
behrensk1@chop.edu